⇨ Lundbeck CEO Kåre Schultz landed the CEO post at Teva $TEVA, winning a $20 million signing bonus as he tackles one of the biggest reorganizations now underway in the industry. The announcement will finally lay to rest long bubbling rumors about who will helm the Israeli company.
⇨ Another senior AstraZeneca R&D exec has jumped ship. Sanjay Jariwala is moving on to Biogen, where he will be the new senior vice president, worldwide medical, reporting to Al Sandrock.
⇨ Roivant Sciences is expanding its management team, with Allen Waxman joining the company as general counsel, Matthew Gline being promoted to chief financial officer and Pavan Cheruvu named chief people officer.
⇨ Amarin Corporation $AMRN announced that Mark W. Salyer has joined the company as chief commercial officer. In this newly created position, Salyer will work to “build on the company’s recent revenue growth and lead future global commercial expansion plans and execution.”
⇨ Axcella Health recruited Manu Chakravarthy as its new CMO and senior vice president of clinical development.
⇨ Karyopharm Therapeutics $KPTI has tapped Michael Falvey as executive vice president, CFO and treasurer. The company also announced that Jatin Shah has assumed the role of vice president, clinical strategy, and Joan Wood has assumed the role of chief human resources Officer.
⇨ Horizon Pharma plc has named Irina Konstantinovsky, executive vice president and chief human resources officer. Konstantinovsky joined Horizon from Baxter International, where she was vice president of global talent. Prior to Baxter, Konstantinovsky spent 15 years in senior partner and director roles at Towers Watson (currently Willis Towers Watson), a global human resources consulting firm.
The best place to read Endpoints News? In your inbox.
Full-text daily reports for those who discover, develop, and market drugs. Join 19,000+ biopharma pros who read Endpoints News by email every day.Free Subscription